 9, 10, 12, [16] [17] [18] 
Numerous reports have corroborated the association of the Australia antigen (Au/SH) with viral hepatitis since the antigen was first reported by Blumberg et al. (2, 3) and by Prince (13 is recorded as the titer end point.
The SGOT levels were determined as described by Karmen (8) . Values The reagents were stored frozen and were repeatedly thawed without evident loss of reactivity.
RESULTS
Au/SH, SGOT levels, and incidence of clinical hepatitis. The study covered a 21-week period during which 185 persons were examined and from whom 348 specimens were assayed for Au/SH. Of the 185, 39 contributed two or more specimens at various time intervals. Single specimens were obtained from 146 persons. Of the 185 persons, 15 with 99 specimens were positive for Au/SH by AG as well as CF procedures.
Antibody to Au/SH was not detected by AG in any of the 348 specimens tested.
Each donor was placed into one of three SGOT categories: 0-40, 41-100, or >101. Persons with multiple specimens were categorized according to the highest SGOT value recorded (Table 1) . SGOT values were obtained on 169 of the 185 persons tested for Au/SH.
The overall impression gained from Table 1 is that a good correlation exists between SGOT values and the incidence of Au/SH. This correlation, however, is not absolute, as 67 % of those with high (>101) SGOT values had no detectable antigen. Moreover, four of seven Au/SHpositive individuals in the middle category (41-100) and one of the eight in the > 101 group had occasional SGOT levels below 40 in sequential samples (see Table 2 ).
Except for the samples mentioned above, no individual with a SGOT level below 40 was found to be positive for Au/SH. It should be noted, however, that single specimens were tested from 72 of the 87 individuals shown in Table 1 . Up to nine serial specimens from 15 of 87 individuals also remained antigen-negative.
Special attention was paid to individuals in whom Au/SH was detected in the initial specimen. Collection of consecutive weekly samples was sufficiently complete to permit an evaluation Table 2 ). of the persistence of antigenemia during the 21 weeks of the study in relation of SGOT levels. The findings on 15 antigen-positive individuals are summarized in Table 2 .
Two or more samples were obtained from 12 of the 15 persons over a period of 21 weeks. In each of these, Au/SH was detected over the entire test period. The SGOT levels were consistently greater than 40 units in 7 of the 12 persons. The SGOT values of the other five persons occasionally decreased to within the normal range while antigenemia persisted without interruption.
As indicated in Table 2 , the number of specimens received from each of the 15 antigen-positive individuals varied greatly; only one specimen was received from 3 of the 15, and 2 to 17 samples were obtained from the other 12. Finally, the three cases of clinical hepatitis recorded during the time of this study occurred in donors with values of over 40 units. All three cases were also found positive for Au/SH.
Correlation between AG and CF results. Data accumulated thus far (Fig. 1) indicate a direct correlation between the results of the two assays. At first, a total of 93 sera were found positive by AG. When all 348 sera were retested by CF, 6 more were found positive by this test. However, when these six were retested for AG by doubling the concentration, they were also found positive. A 100% correlation between these two methods is clearly represented in Fig. 1 
